{
    "medicine_id": "4aebf3105ed3342164524e8b1ca3613617bb463b",
    "platform_id": "DB04923",
    "metadata": {
        "name": "Cleviprex 0 5 mg 1mL Emulsion",
        "composition": "0 5 mg 1mL rhThrombin",
        "clinical_particulars": {
            "therapeutic_indications": "Investigated for use treatment in blood blood forming organ disorders unspecified and hemorrhage",
            "contraindications": {
                "disease": "NA",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "Plasma derived bovine thrombin is used as a topical agent to improve surgical hemostasis but development of antibodies to bovine hemostatic proteins has been associated with increased bleeding and thrombotic complications rhThrombin has a superior immunogenicity profile compared with bovine thrombin 1 5 versus 22 respectively p 0 0001 antibodies developed to the products as defined by seroconversion or significant change in titer units Characterization of the binding antibodies demonstrated none of the anti rhThrombin antibodies neutralized human plasma thrombin",
                "excipients": "NA",
                "incompatibilities": []
            }
        },
        "revision_date": "2023-05-14"
    }
}